Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 14, 2004. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares and does not contain financial performance data for a specific fiscal period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to reporting specific share transactions and fund movements.
Material Changes
The filing details the following specific changes in share interests:
- US Retirement Savings Plan: On April 12, 2004, the number of Ordinary Share ADRs held by the fund increased from 18,773,604 to 18,817,771 at an average price of $41.00. Directors Dr. J.P. Garnier and Dr. T. Yamada are potentially interested in these shares as beneficiaries.
- Employee Trust Transfer: On April 8, 2004, the GSK Trust transferred 1,382 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. Directors Dr. J-P Garnier, Dr. T. Yamada, and Mr. J.D. Coombe are potentially interested in these shares.
- Director Share Purchase: On April 13, 2004, Director Mr. J.D. Coombe acquired 22 Ordinary Shares (11 via personal contribution and 11 via company matching) under the ShareReward Plan at a price of £11.06 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document focuses exclusively on regulatory disclosure of director shareholdings.
Investor Verification Checklist
- Verify the total number of ADRs held in the US Retirement Savings Plan (18,817,771) and the average acquisition price ($41.00).
- Confirm the transfer of 1,382 shares from the GSK Trust to the 1991 Employee Share Option Plan.
- Validate Director J.D. Coombe's acquisition of 22 shares at £11.06 per share under the ShareReward Plan.
- Review the full Form 20-F for comprehensive financial statements, as this 6-K contains no financial metrics.